Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus

被引:5
|
作者
Hu, Zili [1 ,2 ]
Yang, Zhenyun [1 ,2 ]
Wang, Jiongliang [1 ,2 ]
Fu, Yizhen [1 ,2 ]
Hu, Zhiwen [1 ,2 ]
Zhou, Zhongguo [1 ,2 ]
Chen, Minshan [1 ,2 ]
Zhang, Yaojun [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, Dept Liver Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China
关键词
HCC; hepatocellular carcinoma; PVTT; portal vein tumor thrombus; HAIC; neoadjuvant hepatic arterial infusion chemotherapy; hepatoectomy; neoadjuvant therapy; C-REACTIVE PROTEIN; PHASE-II TRIAL; TRANSARTERIAL CHEMOEMBOLIZATION; CISPLATIN; LIVER; RADIOEMBOLIZATION; SORAFENIB; RESECTION; EFFICACY; SAFETY;
D O I
10.3389/fphar.2023.1223632
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background/purpose: The prognosis of hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) is generally poor and hepatectomy is optional for these patients. This study aims to explore the survival benefits of neoadjuvant hepatic arterial infusion chemotherapy (HAIC) for resectable HCC with PVTT.Methods: This retrospective study included 120 resectable HCC patients with PVTT who underwent hepatectomy, from January 2017 to January 2021 at Sun Yat-sen University Cancer Center. Of these patients, the overall survival (OS) and recurrence-free survival (RFS) of 55 patients who received hepatectomy alone (Surgery group) and 65 patients who received neoadjuvant HAIC followed by hepatectomy (HAIC-Surgery group) were compared. Logistic regression analysis was conducted to develop a model predicting the response to neoadjuvant HAIC.Results: The OS rates for the HAIC-Surgery group at 1, 3, and 5 years were 94.9%, 78%, and 66.4%, respectively, compared with 84.6%, 47.6%, and 37.2% in the Surgery group (p < 0.001). The RFS rates were 88.7%, 56.2%, and 38.6% versus 84.9%, 38.3%, and 22.6% (p = 0.002). The subgroup analysis revealed that the survival benefit of neoadjuvant HAIC was limited to patients who responded to it. The logistic model, consisting of AFP and CRP, that predicted the response to neoadjuvant HAIC performed well, with an area under the ROC curve (AUC) of 0.756.Conclusion: Neoadjuvant HAIC followed by hepatectomy is associated with a longer survival outcome than hepatectomy alone for HCC patients with PVTT and the survival benefit is limited to patients who respond to neoadjuvant FOLFOX-HAIC.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Impact of Hepatectomy for Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombus
    Komatsu, Shohei
    Kido, Masahiro
    Kuramitsu, Kaori
    Tsugawa, Daisuke
    Gon, Hidetoshi
    Fukushima, Kenji
    Urade, Takeshi
    Yanagimoto, Hiroaki
    Toyama, Hirochika
    Fukumoto, Takumi
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (04) : 822 - 830
  • [42] Treatment of Hepatocellular Carcinoma with Portal Vein Thrombosis by Sorafenib Combined with Hepatic Arterial Infusion Chemotherapy
    Yang, Mi Yean
    Jeong, Soung Won
    Kim, Dong Kyun
    Kim, Sang Gyune
    Jang, Jae Young
    Kim, Young Seok
    Lee, Joon Seong
    Kim, Boo Sung
    Kim, Jung Hoon
    Kim, Yong Jae
    GUT AND LIVER, 2010, 4 (03) : 423 - 427
  • [43] Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy
    Li, Nan
    Feng, Shuang
    Xue, Jie
    Wei, Xu-Biao
    Shi, Jie
    Guo, Wei-Xing
    Lau, Wan-Yee
    Wu, Meng-Chao
    Cheng, Shu-Qun
    Meng, Yan
    HPB, 2016, 18 (06) : 549 - 556
  • [44] A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Song, Do Seon
    Song, Myeong Jun
    Bae, Si Hyun
    Chung, Woo Jin
    Jang, Jae Young
    Kim, Young Seok
    Lee, Sae Hwan
    Park, Jun Yong
    Yim, Hyung Joon
    Cho, Sung Bum
    Park, Soo Young
    Yang, Jin Mo
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (04) : 445 - 454
  • [45] A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Do Seon Song
    Myeong Jun Song
    Si Hyun Bae
    Woo Jin Chung
    Jae Young Jang
    Young Seok Kim
    Sae Hwan Lee
    Jun Yong Park
    Hyung Joon Yim
    Sung Bum Cho
    Soo Young Park
    Jin Mo Yang
    Journal of Gastroenterology, 2015, 50 : 445 - 454
  • [46] Pathological Complete Remission of Advanced Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis by Hepatic Arterial Infusion Chemotherapy
    Kim, Yong Gil
    Eun, Jong Ryul
    Kim, Tae Nyeun
    Lee, Heon Ju
    Kim, Jae Woon
    Chang, Jay Chun
    Yun, Sung Su
    Choi, Joon Hyuk
    GUT AND LIVER, 2010, 4 (02) : 266 - 269
  • [47] Sorafenib versus Hepatic Arterial Infusion Chemotherapy as Initial Treatment for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombosis
    Moriguchi, Michihisa
    Aramaki, Takeshi
    Nishiofuku, Hideyuki
    Sato, Rui
    Asakura, Koiku
    Yamaguchi, Kanji
    Tanaka, Toshihiro
    Endo, Masahiro
    Itoh, Yoshito
    LIVER CANCER, 2017, 6 (04) : 275 - 286
  • [48] A PHASE II TRIAL OF HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH CISPLATIN FOR ADVANCED HEPATOCELLULAR CARCINOMA WITH PORTAL VEIN TUMOR THROMBOSIS
    Furuse, J.
    Ikeda, M.
    Okusaka, T.
    Nakachi, K.
    Morizane, C.
    Ueno, H.
    Yamaura, H.
    Inaba, Y.
    Satake, M.
    Arai, Y.
    ANNALS OF ONCOLOGY, 2008, 19 : 178 - 178
  • [49] A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Furuse, J.
    Ikeda, M.
    Okusaka, T.
    Nakachi, K.
    Morizane, C.
    Ueno, H.
    Yamaura, H.
    Inaba, Y.
    Satake, M.
    Arai, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis
    Liu, Miao
    Shi, Junyi
    Mou, Tong
    Wang, Yang
    Wu, Zhongjun
    Shen, Ai
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (08) : 1277 - 1287